BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
Confirm your vial composition
This phase is also where visceral fat reduction becomes measurable
That said, some companies skirt the law by labeling BPC157 as a research chemical not for human use. While technically not illegal to possess in this form, it's a legal gray areaand the FDA has already sent warning letters to vendors marketing it for recovery or performance purposes
Current Neuropharmacology For laboratory and in-vitro research use only
Current Neuropharmacology, 14(8), 857-865